Subscribe to your choice of industry specific newsletters, save $100 on conferences, search member directories, comment on stories and more. Free to qualified media, marketing and advertising professionals.

While other MediaPost newsletters and articles remain free to all ... our new Research Intelligencer service is reserved for paid subscribers ...

Subscribe today to gain access to every Research Intelligencer article we publish as well as the exclusive daily newsletter, full access to The MediaPost Cases, first-look research and daily insights from Joe Mandese, Editor in Chief.

Become a subscriber today!

Become a free MediaPost member now to read this article

Unlimited articles every day
Keep up-to-date with media, marketing and advertising news
Invitations to exclusive industry events and research

Subscribe to MediaDailyNews

Clarification: NextMed Did Not Admit Or Deny FTC Allegations For Settling Deceptive Ad Charges

by The Editor , October 2, 2025

An article in the July 15 edition of MediaDailyNews (“Telemedicine Company Ran Ads With Misleading Prices, Fake Ozempic Testimonials, FTC Charges”) omitted that the company, NextMed, neither admitted or denied the allegations made in the Federal Trade Commission’s complaint or order, but agreed to the terms ordered by the commission to settle the complaint. The original article has been updated and links to this clarification.

Next story loading